Combining vasculature disrupting agent and toll-like receptor 7/8 agonist for cancer therapy

This study evaluates the effect of combination of two different treatment regimens for solid tumor therapy: vasculature targeting agent and immune-stimulation. Poly lactide-co-glycolide (PLGA) nanoparticles were synthesized for intracellular delivery of toll-like receptor (TLR) 7/8 agonist—gardiquim...

Descripción completa

Detalles Bibliográficos
Autores principales: Seth, Anushree, Lee, Hyunseung, Cho, Mi Young, Park, Cheongsoo, Korm, Sovannarith, Lee, Joo-Yong, Choi, Inpyo, Lim, Yong Taik, Hong, Kwan Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354915/
https://www.ncbi.nlm.nih.gov/pubmed/28036266
http://dx.doi.org/10.18632/oncotarget.14260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354915/
https://www.ncbi.nlm.nih.gov/pubmed/28036266
http://dx.doi.org/10.18632/oncotarget.14260

Ejemplares similares